Cryptolepine and Nibima inhibit hepatitis B virus replication-Reference-Cited by-同舟云学术

Cryptolepine and Nibima inhibit hepatitis B virus replication

Published:2021-09 Issue: Volume:13 Page:e00942
ISSN:2468-2276
Container-title:Scientific African
language:en
Short-container-title:Scientific African

Author:

Domfeh Seth  A.,Narkwa Patrick  W.,Quaye Osbourne,Kusi Kwadwo  A.,Rivera Odalys,Danaah Martin  M.,Musah Baba  A.N.,Awandare Gordon  A.,Mensah Kwesi  B.,Mutocheluh Mohamed

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference38 articles.

1. Estimations of the worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. Cancer burden in Africa and opportunities for prevention;Jemal;Cancer,2012

3. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model;Fathy;Canadian J. Physiol. Pharmacol.,2017

4. Epidemiology of hepatocellular carcinoma;Bosch;Clin. Liver Dis.,2005

5. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;Cancer J. Clin.,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of Nibima and Immunim, two Ghanaian herbal medicines in the management of mild COVID‐19: A case report;Clinical Case Reports;2024-02

2. Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT/β-Catenin Signaling;Pharmaceuticals;2023-07-19

3. Genetic diversity and population structure of the antimalarial plant Cryptolepis sanguinolenta in Ghana;Frontiers in Conservation Science;2022-10-04

4. A Compilation of Synthetic Strategies to Access the Most Utilized Indoloquinoline Motifs;Chemistry – An Asian Journal;2022-02-21